MedPath

Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy.

Not Applicable
Recruiting
Conditions
Prostate Cancer
Interventions
Behavioral: Multimodal prehabilitation
Registration Number
NCT05553327
Lead Sponsor
Hospital Clinic of Barcelona
Brief Summary

The aim of the study is to verify whether a multimodal prehabilitation programme prior to robotic radical prostatectomy contributes to a faster recovery of quality of life after surgery, to better functional results (including erectile function and continence) and to less perioperative anxiety.

Detailed Description

Single center randomized clinical trial including prostate cancer patients undergoing robotic-assisted radical prostatectomy at the Hospital Clínic de Barcelona. Patients will be randomized into two groups, one receiving multimodal prehabilitation and the other a control group. Multimodal prehabilitation consists of improving the functional and mental capacity of an individual to cope with a significant stressor, in this case surgery. The design of our prehabilitation program, lasting 4 weeks prior to surgery, consists of three parts; physical state, nutritional state and mental health. In the case of physical condition, a series of supervised and "home-based" exercises (aerobic and functional) will be carried out in addition to specific pelvic floor exercises. The nutritional status will be evaluated by a nutritionist. Diet guidelines will be given and if there are deficiencies they will be supplemented. Regarding mental health, a visit will be made with a psychologist and group and online therapies will be offered. The outcomes will be evaluated before starting the prehabilitation program, at the end of it (just before surgery) and at 4, 8 and 16 weeks after surgery. The outcomes include variables on physical, nutritional and mental state, health-related quality of life (HRQoL), and continence and erectile function.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
100
Inclusion Criteria
  • Patients with localized prostate cancer
  • Candidates to robotic radical prostatectomy
Exclusion Criteria
  • Non-localized prostate cancer
  • Previous history of pelvic radiotherapy or pelvic surgery
  • Failure to consent,
  • Unwillingness to participate
  • Anticipated failure to adhere to the program sessions.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Multimodal prehabilitationMultimodal prehabilitationThis patients will receive the pre-hab program
Primary Outcome Measures
NameTimeMethod
Perioperative anxiety levelsWeek 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)

Change in perioperative anxiety levels

Hospital Anxiety \& Depression (HAD )

Scoring scale: 0-21 0-7 = Normal 8-10 = Borderline abnormal (borderline case) 11-21 = Abnormal (case)

Continence recoveryWeek 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)

Change in continence during the prehabilitation program and postoperative recovery.

International Consultation on Incontinence Questionnaire (ICIQ)

Scoring scale: 0-21 Higher value means worse outcome

Secondary Outcome Measures
NameTimeMethod
Change in physical status by STSWeek 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)

Sit-to-Stand (STS)

Time needed for 5 repeated chair rises. Higher time means worse physical status.

Perceived application usabilityWeek 4

Usability questionare

Includes a combination of the System Usability Scale (SUS) and the Net Promoter Score (NPS).

Scoring scale: 0-100 Higher value indicates better perceived usability

Change in physical status by 6MWTWeek 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)

6 Minute Walk Test (6MWT)

Distance covered over a time of 6 minutes. Higher time means worse physical status.

Erectile function recoveryWeek 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)

International Index Erectile Function (IIEF-5)

Change in erectile function during the prehabilitation program and postoperative recovery.

Scoring scale: 5-25 22-25: No erectile dysfunction 17-21: Mild erectile dysfunction 12-16: Mild to moderate erectile dysfunction 8-11: Moderate erectile dysfunction 5-7: Severe erectile dysfunction

Change in perceived general quality of lifeWeek 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)

EORTC QLQ - C30

Scoring scale: 0-100 Higher value indicates higher perceived general quality of life

Early postoperative morbidity by CCIWeek 8 (post-op)

Comprehensive Complications Index (CII)

Scoring scale: 0-100 Higher value indicates more severe complication

Change in perception of physical statusWeek 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)

Yale physical activity survey (YPAS)

Part 1 - Scoring scale: 0-85680 kcal/week Part 2 - Scoring scale: 0-142 Part 3 - Scoring scale: 0.7-1.3

Higher values indicates higher activity.

Change in perceived prostate quality of lifeWeek 0 and 4 (pre-op); weeks 8, 16 and 28 (post-op)

EORTC QLQ - PR25

Scoring scale: 0-100 Higher value indicates higher perceived prostate quality of life

Early postoperative morbidity by CDCWeek 8 (post-op)

Clavien-Dindo Classification (CDC)

Scoring scale: 1-5 Higher value indicates more severe complication

Nutritional statusWeek 0 and 4

Nutritionist final evaluation summarized as optimal or suboptimal by the specialist.

Satisfaction with the multimodal programWeek 4

Satisfaction questionnaire

Scoring scale: 0-45 Higher value indicates higher satisfaction

Trial Locations

Locations (1)

Hospital Clinic de Barcelona

🇪🇸

Barcelona, Catalonia, Spain

© Copyright 2025. All Rights Reserved by MedPath